Compounded Rapamycin

We consider Rapamycin to be the most promising healthspan-promoting intervention for its role in slowing down the formation of senescent cells. By slowing down the formation of senescent cells and their harmful effects, rapamycin usage effectively delays the onset of age related diseases. However, bioavailability concerns exist for Compounded Rapamycin.